Cabergoline
Brand names,
Cabergoline
Analogs
Cabergoline
Brand Names Mixture
Cabergoline
Chemical_Formula
C26H37N5O2
Cabergoline
RX_link
http://www.rxlist.com/cgi/generic3/cabergoline.htm
Cabergoline
fda sheet
Cabergoline
msds (material safety sheet)
Cabergoline
Synthesis Reference
No information avaliable
Cabergoline
Molecular Weight
451.604 g/mol
Cabergoline
Melting Point
102 - 104 oC
Cabergoline
H2O Solubility
Insoluble
Cabergoline
State
Solid
Cabergoline
LogP
2.855
Cabergoline
Dosage Forms
Tablets for oral administration (0.5 mg)
Cabergoline
Indication
For the treatment of hyperprolactinemic disorders, either idiopathic or due to pituitary adenomas.
Cabergoline
Pharmacology
Cabergoline is a dopamine receptor agonist and uncategorized drug which suppresses the production of prolactin in pituitary gland. It is an ergot-derivative. It has at times been used as an adjunct to SSRI antidepressants as there is some evidence that it counteracts certain side effects of those drugs such as reduced libido and anorgasmia. It also has been suggested online that it has a possible recreational use in reducing or eliminating the male refractory period.
Cabergoline
Absorption
First-pass effect is seen, however the absolute bioavailability is unknown.
Cabergoline
side effects and Toxicity
Overdosage might be expected to produce nasal congestion, syncope, or hallucinations.
Cabergoline
Patient Information
Cabergoline
Organisms Affected
Humans and other mammals